Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN AUROBINDO PHARMA LUPIN/
AUROBINDO PHARMA
 
P/E (TTM) x 40.7 23.0 177.3% View Chart
P/BV x 6.0 2.4 251.7% View Chart
Dividend Yield % 0.2 0.3 89.8%  

Financials

 LUPIN   AUROBINDO PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-23
AUROBINDO PHARMA
Mar-23
LUPIN/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs799715 111.8%   
Low Rs583397 146.8%   
Sales per share (Unadj.) Rs365.8424.2 86.2%  
Earnings per share (Unadj.) Rs9.832.9 29.9%  
Cash flow per share (Unadj.) Rs29.254.1 53.9%  
Dividends per share (Unadj.) Rs4.003.00 133.3%  
Avg Dividend yield %0.60.5 107.3%  
Book value per share (Unadj.) Rs270.7458.1 59.1%  
Shares outstanding (eoy) m454.98585.94 77.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.91.3 144.1%   
Avg P/E ratio x70.216.9 415.5%  
P/CF ratio (eoy) x23.710.3 230.5%  
Price / Book Value ratio x2.61.2 210.3%  
Dividend payout %40.79.1 445.8%   
Avg Mkt Cap Rs m314,381325,753 96.5%   
No. of employees `000NANA-   
Total wages/salary Rs m30,87235,223 87.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m166,417248,554 67.0%  
Other income Rs m1,5092,906 51.9%   
Total revenues Rs m167,926251,460 66.8%   
Gross profit Rs m17,20637,070 46.4%  
Depreciation Rs m8,80712,446 70.8%   
Interest Rs m2,7431,405 195.3%   
Profit before tax Rs m7,16526,125 27.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,6886,849 39.2%   
Profit after tax Rs m4,47719,277 23.2%  
Gross profit margin %10.314.9 69.3%  
Effective tax rate %37.526.2 143.1%   
Net profit margin %2.77.8 34.7%  
BALANCE SHEET DATA
Current assets Rs m124,513214,599 58.0%   
Current liabilities Rs m92,654114,938 80.6%   
Net working cap to sales %19.140.1 47.7%  
Current ratio x1.31.9 72.0%  
Inventory Days Days2621 127.2%  
Debtors Days Days9866 149.8%  
Net fixed assets Rs m103,490176,668 58.6%   
Share capital Rs m910586 155.3%   
"Free" reserves Rs m122,246267,813 45.6%   
Net worth Rs m123,156268,399 45.9%   
Long term debt Rs m2756,190 4.4%   
Total assets Rs m228,003392,125 58.1%  
Interest coverage x3.619.6 18.4%   
Debt to equity ratio x00 9.7%  
Sales to assets ratio x0.70.6 115.1%   
Return on assets %3.25.3 60.0%  
Return on equity %3.67.2 50.6%  
Return on capital %8.010.0 80.1%  
Exports to sales %033.7 0.0%   
Imports to sales %015.3 0.0%   
Exports (fob) Rs mNA83,703 0.0%   
Imports (cif) Rs mNA38,060 0.0%   
Fx inflow Rs m48,05785,483 56.2%   
Fx outflow Rs m21,75241,447 52.5%   
Net fx Rs m26,30644,036 59.7%   
CASH FLOW
From Operations Rs m18,97223,868 79.5%  
From Investments Rs m-12,868-39,778 32.3%  
From Financial Activity Rs m-3,37318,144 -18.6%  
Net Cashflow Rs m2,7322,298 118.9%  

Share Holding

Indian Promoters % 46.8 48.8 95.9%  
Foreign collaborators % 0.3 3.1 9.1%  
Indian inst/Mut Fund % 45.8 41.3 110.9%  
FIIs % 16.1 20.7 77.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.0 48.2 109.9%  
Shareholders   281,542 241,944 116.4%  
Pledged promoter(s) holding % 0.0 20.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Lupin vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Lupin vs Aurobindo Pharma Share Price Performance

Period Lupin Aurobindo Pharma S&P BSE HEALTHCARE
1-Day 1.23% 1.82% 1.18%
1-Month 0.15% 5.96% -0.75%
1-Year 151.14% 113.07% 61.82%
3-Year CAGR 17.13% 7.78% 18.16%
5-Year CAGR 17.42% 7.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the Lupin share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of Lupin hold a 47.0% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, Lupin paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 40.7%.

Aurobindo Pharma paid Rs 3.0, and its dividend payout ratio stood at 9.1%.

You may visit here to review the dividend history of Lupin, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.